Delivery Order SPE2DB24D2013-SPE2DB25FCKCG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens, valued at $1,862.88. This firm fixed-price delivery order, which concludes on July 24, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $2,289.58 delivery order to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ML insulin pens on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical procurement under DLA's Medical Supply Chain operations. The award was issued to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,725.61 to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ml insulin pens on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,397 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens, with completion scheduled for August 19, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $1,003.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ML insulin pens, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,541.58 to AmerisourceBergen Drug Corp for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens. The contract, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price delivery order under a competitive procurement with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,824.80 for NovoLog Mix 70-30 FlexPen 3mL insulin pens on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,054.35. This is a firm fixed price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The performance...
- The Defense Logistics Agency awarded a delivery order valued at $2,807.97 to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3mL insulin pens on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement of pharmaceutical products for federal medical supply needs. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $2,108.70. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCKCGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens, a widely-used combination insulin product for diabetes management. This firm fixed-price delivery order, valued at $1,252.30, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The award was made through competitive procurement with no set-aside designation, and the pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company's comprehensive IDC with DLA enables it to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains, supporting the Defense Health Agency and other government healthcare systems globally. This delivery order exemplifies AmerisourceBergen's ongoing role as a primary pharmaceutical supplier for the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/4/25 |